| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Adjusted EPS | $2.58 (+24% YoY) | $2.42 (+23% YoY) | 6 cent sequential decline but strong YoY momentum |
| Adjusted Earnings | $1.7B (+18% YoY) | $1.6B (+18% YoY) | Flat growth rate but $100M absolute decline |
| Group Benefits Adjusted Earnings | $465M (+12% YoY) | $439M (+19% YoY) | 700 bps acceleration despite 6% absolute decline |
| Group Life Mortality Ratio | 81.1% (Q4) | 80.1% (Q1) | 100 bps improvement to exceptional levels |
| RIS Adjusted Earnings | $454M (+18% YoY) | $451M (+11% YoY) | 700 bps growth deceleration |
| Asia Adjusted Earnings | $444M (flat YoY) | $487M (+31% YoY) | Explosive 31 point acceleration |
| Variable Investment Income | $497M (Q4) | $518M (Q1) | $21M sequential gain, 2.9% PE returns |
| MIM Adjusted Earnings | $60M (full year 2025) | $47M (Q1) | Strong quarterly run rate vs $28M Q1 2025 |
| Direct Expense Ratio | 11.7% (full year) | 11.9% (Q1) | 20 bps uptick but beating 12.1% target |
| Adjusted ROE | 16% (full year) | 17% (Q1) | 100 bps improvement to top of target range |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.